ONCODESIGN PRECISION MEDICINE financial statements, including revenue, expenses, profit, and loss
The total revenue of ALOPM for the last semiannual is 326.92 k EUR, and it's 56.13% lower compared to the previous semiannual. The net income of H2 23 is -4.15 M EUR.